AURAL
AURAL is a French non-profit healthcare association founded in 1974 that provides dialysis treatment, nephrology consultations, and telemedicine services to 1,310 chronic kidney disease patients across 19 sites in the Rhône-Alpes region, reimbursed through the French Sécurité Sociale.
- Company typePrivate
- Founded1974
- HeadquartersLyon, France
- Headcount101–250
- GTM typeB2C
- OfferingServices
What AURAL does
AURAL (Association pour l'Utilisation du Rein Artificiel dans la région Lyonnaise) is a French private non-profit healthcare association founded in 1974 and headquartered in Lyon, France. It operates as an Établissement de Santé Privé d'Intérêt Collectif (ESPIC) governed under French loi 1901 association law and is a member of FEHAP, the federation of non-profit hospital and home-care establishments. The organization specializes in chronic kidney disease treatment and delivers renal replacement therapy including hemodialysis, hemodiafiltration, daily hemodialysis, and peritoneal dialysis, alongside external nephrology consultations and patient education programs.
AURAL operates 19 dialysis treatment sites and 2 health centers across the Rhône-Alpes region, employing 360 staff and serving 1,310 patients. Its technology infrastructure includes telemedicine capabilities deployed at 5 sites (Lyon 8ème, Lyon 4ème, Oyonnax, Chambéry, Albertville), an in-house biomedical maintenance service for dialysis generators, and a service pharmacy responsible for water quality in hemodialysis. The organization also integrates with Doctolib for online appointment booking and REINOMED for clinical registry purposes. In 2019, it launched a Sustainable Development Initiative targeting reduced water and energy consumption and waste reduction.
The revenue model is based on reimbursement through the French national health insurance system (Sécurité Sociale), with no private pay or premium pricing. Additional non-operating capital has been received via EU Fonds pour la Modernisation et l'Investissement en Santé (FMIS) grants totaling €482K over 2021–2024 for infrastructure modernization. As a non-profit, AURAL does not have external equity investors; resources are reinvested into patient care quality and infrastructure.
AURAL firmographics
Firmographics- Name
- AURAL
- Legal name
- Association pour l'Utilisation du Rein Artificiel dans la région Lyonnaise
- Website
- https://auralyon.org
- Company type
- Private
- Founded year
- 1974
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- AURAL is a French non-profit healthcare association founded in 1974 that provides dialysis treatment, nephrology consultations, and telemedicine services to 1,310 chronic kidney disease patients across 19 sites in the Rhône-Alpes region, reimbursed through the French Sécurité Sociale.
- Ownership category
- akta.pro rank
AURAL industry classification
Industry- Product category
- Dialysis and Nephrology Services
- NAICS
- Kidney Dialysis Centers (621492), Ambulatory Health Care Services (621)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Home Health Care Services (8082)
- akta.pro primary industry
- Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC)
- akta.pro secondary industries
- Outpatient Dialysis & Kidney Care Centers (HLAFABAE), Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support) (HLALAFAC), Home Dialysis Support & Training Providers (HLAFAEAG)
Keywords
Where AURAL is headquartered
LocationHeadquarters
- HQ city
- Lyon
- HQ country
- France
- HQ region
- Europe
Offices5 records
Markets served
AURAL business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Healthcare service reimbursement: As a non-profit private healthcare establishment (Établissement de Santé Privé à but non lucratif) governed by a loi 1901 association, AURAL operates within the French public healthcare system (Sécurité Sociale). Services are reimbursed through French national health insurance for dialysis treatments and nephrology consultations.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
AURAL product offering
Product offeringCore offering
AURAL provides renal replacement therapy for chronic kidney disease patients across 19 sites in the Rhône-Alpes region, including hemodialysis, hemodiafiltration, daily hemodialysis, and peritoneal dialysis. The organization also operates health centers offering external nephrology consultations and provides telemedicine-based remote patient monitoring at five sites, supported by therapeutic patient education, dietary, psychological, and social services.
Product overview
AURAL is a private non-profit healthcare establishment (Établissement de Santé Privé à but non lucratif, loi 1901) founded in 1974, specializing in chronic kidney disease treatment. The organization operates a unified dialysis service network with three interconnected offerings: hemodialysis and home dialysis treatments (the core service), nephrology consultations (offered at dedicated health centers), and telemedicine (enabling remote patient monitoring across multiple sites). These services work together to provide comprehensive renal care from initial consultations through various dialysis modalities to ongoing remote follow-up.
Differentiator
Problem solved
Functional benefit
Products and services
- Dialysis Treatment Services Renal replacement therapy including hemodialysis in-center and home hemodialysis options, hemodiafiltration, daily hemodialysis, and peritoneal dialysis treatments provided across 19 sites in the Rhône-Alpes region for chronic kidney disease patients.
- Nephrology Consultations External nephrology consultations at dedicated health centers in Lyon 8ème and Bourgoin-Jallieu, staffed by nephrologist physicians and dedicated nursing teams, provided without fee overruns (sans dépassement d'honoraires).
- Telemedicine Services
Quantifiable outcome
- 1310 patients treated across multiple dialysis modalities
- +2 more outcomes
Companies that use AURAL
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
AURAL technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature3 records
AURAL partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- FEHAP (Fédération des Établissements Hospitaliers et d'Aide à la Personne)coreAURAL, as an Établissement de Santé Privé d'Intérêt Collectif (ESPIC), is a member of FEHAP, the Federation of Hospital Establishments and Home Care Organizations. This federation represents non-profit healthcare establishments in France.
- France ReinminorPartnership with France Rein, an association dedicated to supporting people with kidney diseases since 1972. France Rein publishes the practical guide for dialysis patients (3rd edition), which AURAL promotes to its patients as an informative resource.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
AURAL competitors and assessment
Company assessmentDirect peers
- Calydial: Calydial is another non-profit dialysis association operating in the Lyon metropolitan area, offering hemodialysis, peritoneal dialysis, and nephrology consultations with a similar ESPIC-style model. It is a direct peer to AURAL because it competes in the same Rhône-Alpes catchment for both dialysis patients and nephrology referrals.
- AGDUC: AGDUC is a French regional non-profit dialysis association operating multiple dialysis centers, similar in legal form (loi 1901 association) and operating model to AURAL. It is a direct peer because it offers the same multi-modality dialysis services under the same French public reimbursement framework.
Others
- France Rein: France Rein is a French national kidney patient association that publishes patient education materials in partnership with dialysis providers, including AURAL. It is an ecosystem/other peer rather than a direct competitor, functioning as a patient advocacy organization that influences the broader nephrology care environment in which AURAL operates.
- Renaloo: Renaloo is a French association of kidney patients that advocates for better access to treatment and patient choice, including home dialysis. It is an other/ecosystem peer to AURAL because it is not a service provider but shapes patient expectations and policy direction affecting AURAL's service mix.
Broad incumbents
- Diaverum France: Diaverum is one of the world's largest independent dialysis service providers, operating a global network of clinics including sites in France. It is a broad incumbent peer to AURAL because it offers the same hemodialysis and peritoneal dialysis services but with materially greater scale, geographic reach, and corporate procurement power.
- Fresenius Medical Care (NephroCare): Fresenius Medical Care is the global leader in dialysis products and services, operating the NephroCare clinic network across dozens of countries including France. It is a broad incumbent peer to AURAL because it provides the same dialysis modalities with vertically integrated equipment manufacturing and substantially greater scale.
- B. Braun Avitum: B. Braun Avitum operates a network of dialysis centers across Europe and offers integrated dialysis services with in-house equipment manufacturing. It is a broad incumbent peer to AURAL because it competes in the same chronic hemodialysis market with greater scale, integrated supply chain, and pan-European footprint.
Regional players
- Hospices Civils de Lyon (HCL): HCL is the major public teaching hospital network in the Lyon region that also operates dialysis services and nephrology consultations. It is a regional peer to AURAL because both operate in the same Rhône-Alpes catchment area and serve overlapping CKD patients, though HCL provides broader acute hospital services while AURAL focuses on outpatient chronic dialysis.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
AURAL social profiles
Digital presenceAURAL financial estimates
Financial estimateRevenue estimate
Valuation estimate
AURAL leadership team
Management profileNumber of profiles
Profiles2 records
AURAL funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AURAL M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AURAL
What does AURAL do?
AURAL provides renal replacement therapy for chronic kidney disease patients across 19 sites in the Rhône-Alpes region, including hemodialysis, hemodiafiltration, daily hemodialysis, and peritoneal dialysis. The organization also operates health centers offering external nephrology consultations and provides telemedicine-based remote patient monitoring at five sites, supported by therapeutic patient education, dietary, psychological, and social services.
Is AURAL a public or private company?
AURAL is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was AURAL founded?
AURAL was founded in 1974. It employs 101 to 250 people.
Where is AURAL based?
AURAL is headquartered in Lyon, France, in the Europe region.
How does AURAL make money?
One revenue line is on record: healthcare service reimbursement.
Who are AURAL's main competitors?
Direct peers on record are Calydial and AGDUC. Others are France Rein and Renaloo. Broad incumbents are Diaverum France, Fresenius Medical Care (NephroCare) and B. Braun Avitum. Hospices Civils de Lyon (HCL) is listed as a regional player.
Does AURAL have an API?
No public API is recorded for AURAL.
What industry is AURAL in?
AURAL's product category is Dialysis and Nephrology Services. Its primary akta.pro industry code is HLAKAHAC, Dialysis Services (Hemodialysis & Peritoneal Dialysis), with a secondary code of HLAFABAE, Outpatient Dialysis & Kidney Care Centers. Its NAICS code is 621492 and its SIC code is 8093.